J Blatt

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi Drug repurposing in pediatrics and pediatric hematology oncology
    Julie Blatt
    Department of Pediatrics and the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA
    Drug Discov Today 18:4-10. 2013
  2. ncbi β-blockers for infantile hemangiomas: a single-institution experience
    Julie Blatt
    University of North Carolina School of Medicine and the University of North Carolina School of Medicine Vascular Anomalies Clinic, Chapel Hill, NC, USA
    Clin Pediatr (Phila) 50:757-63. 2011
  3. ncbi Treatment of childhood kaposiform hemangioendothelioma with sirolimus
    Julie Blatt
    Division of Pediatric Hematology Oncology, Vascular Lesions Clinic, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Pediatr Blood Cancer 55:1396-8. 2010
  4. ncbi Isolated central nervous system relapse in an adolescent with acute myelomonocytic leukemia, Charcot Marie Tooth syndrome, and paraneoplastic autoantibody
    Julie Blatt
    Division of Pediatric Hematology Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Pediatr Hematol Oncol 32:571-3. 2010
  5. ncbi Autism in children and adolescents with cancer
    Julie Blatt
    Division of Pediatric Hematology Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7236, USA
    Pediatr Blood Cancer 54:144-7. 2010
  6. ncbi Wilms tumor associated with hirschsprung disease
    Julie Blatt
    Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    J Pediatr Hematol Oncol 29:858-9. 2007
  7. ncbi Pregnancy outcome in long-term survivors of childhood cancer
    J Blatt
    Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill 27599 7220, USA
    Med Pediatr Oncol 33:29-33. 1999
  8. ncbi Childhood non-Hodgkin lymphoma presenting as hemophagocytic syndrome
    Julie Blatt
    Division of Pediatric Hematolotv Oncology, University of North Carolina, Chapel Hill 27599, USA
    Pediatr Hematol Oncol 19:45-9. 2002
  9. ncbi Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol
    Julie Blatt
    Department of Pediatrics, The University of North Carolina School of Medicine at Chapel Hill, North Carolina 27599 7220, USA
    J Pediatr Hematol Oncol 25:635-6. 2003
  10. ncbi Posterior fossa neoplasm and PHACES syndrome: a case report
    Katharine E Wallen
    Division of Pediatric Hematology Oncology, The University of North Carolina, Chapel Hill, NC 27599 7236, USA
    J Pediatr Hematol Oncol 31:203-5. 2009

Detail Information

Publications24

  1. ncbi Drug repurposing in pediatrics and pediatric hematology oncology
    Julie Blatt
    Department of Pediatrics and the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA
    Drug Discov Today 18:4-10. 2013
    ..The observant clinician, pharmacologist and translational bioinformatician, as well as structural targeting, will have a role in discovering new repurposing opportunities...
  2. ncbi β-blockers for infantile hemangiomas: a single-institution experience
    Julie Blatt
    University of North Carolina School of Medicine and the University of North Carolina School of Medicine Vascular Anomalies Clinic, Chapel Hill, NC, USA
    Clin Pediatr (Phila) 50:757-63. 2011
    ..They suggest daily home monitoring of patients for the first 2 weeks of initiating or increasing doses. Frequent feeding of infants and young children on this drug is recommended...
  3. ncbi Treatment of childhood kaposiform hemangioendothelioma with sirolimus
    Julie Blatt
    Division of Pediatric Hematology Oncology, Vascular Lesions Clinic, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Pediatr Blood Cancer 55:1396-8. 2010
    ..1 mg/kg/day). This case provides further rationale for clinical trials of sirolimus in the treatment of vascular lesions...
  4. ncbi Isolated central nervous system relapse in an adolescent with acute myelomonocytic leukemia, Charcot Marie Tooth syndrome, and paraneoplastic autoantibody
    Julie Blatt
    Division of Pediatric Hematology Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Pediatr Hematol Oncol 32:571-3. 2010
    ..Titres to VGKC, a paraneoplastic autoantibody, were elevated, suggesting an additional mechanism for the polyneuropathy. This case extends the clinical spectrum of cancer with CMT, and of paraneoplastic disorders...
  5. ncbi Autism in children and adolescents with cancer
    Julie Blatt
    Division of Pediatric Hematology Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7236, USA
    Pediatr Blood Cancer 54:144-7. 2010
    ..We explore possible associations between AD and childhood cancer...
  6. ncbi Wilms tumor associated with hirschsprung disease
    Julie Blatt
    Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    J Pediatr Hematol Oncol 29:858-9. 2007
    ..Although this limited evaluation failed to show abnormalities, we speculate that comprehensive analysis of the RET gene may identify mutations to account for the development of WT in this and other children with WT...
  7. ncbi Pregnancy outcome in long-term survivors of childhood cancer
    J Blatt
    Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill 27599 7220, USA
    Med Pediatr Oncol 33:29-33. 1999
    ..By the year 2010, 1/250 young adults will be long-term survivors of childhood cancer. One of the major concerns is whether they will be able to have healthy children...
  8. ncbi Childhood non-Hodgkin lymphoma presenting as hemophagocytic syndrome
    Julie Blatt
    Division of Pediatric Hematolotv Oncology, University of North Carolina, Chapel Hill 27599, USA
    Pediatr Hematol Oncol 19:45-9. 2002
    ..In children with systenic hemophagocytosis, a diagnosis of NHL should be aggressively pursued...
  9. ncbi Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol
    Julie Blatt
    Department of Pediatrics, The University of North Carolina School of Medicine at Chapel Hill, North Carolina 27599 7220, USA
    J Pediatr Hematol Oncol 25:635-6. 2003
    ..This case, while anecdotal, suggests that a transgenerational history of DES exposure should be noted, and that granddaughters with persistent abdominal pain even during childhood may need evaluation for genital tract abnormalities...
  10. ncbi Posterior fossa neoplasm and PHACES syndrome: a case report
    Katharine E Wallen
    Division of Pediatric Hematology Oncology, The University of North Carolina, Chapel Hill, NC 27599 7236, USA
    J Pediatr Hematol Oncol 31:203-5. 2009
    ..Cerebellar pilocytic astrocytoma may be a rare manifestation of the posterior fossa malformations of PHACES...
  11. ncbi Monitoring pulmonary complications in long-term childhood cancer survivors: guidelines for the primary care physician
    Allen Liles
    Department of Medicine Pediatrics, The University of North Carolina, Women s Hospital UNC, Chapel Hill, NC 27599, USA
    Cleve Clin J Med 75:531-9. 2008
    ..The Children's Oncology Group (COG) has issued guidelines on this topic (www.survivorshipguidelines.org). This review summarizies the findings of the COG Guideline Task Force on Pulmonary Complications with respect to pulmonary toxicity...
  12. ncbi IGF-I receptor inhibition combined with rapamycin or temsirolimus inhibits neuroblastoma cell growth
    Don W Coulter
    Division of Hematology Oncology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7220, USA
    Anticancer Res 28:1509-16. 2008
    ..Inhibition of IGF1R signaling can be accomplished by other agents, including rapamycin or temsirolimus, which target mTOR (mammalian target of rapamycin)...
  13. ncbi Visceral larval migrans masquerading as metastatic disease in a toddler with Wilms tumor
    Andrew Anderson
    Department of Radiology, University of North Carolina School of Medicine, 3325 Old Infirmary Bldg, Campus Box 7510, Chapel Hill, NC 27599 7510, USA
    Pediatr Radiol 36:265-7. 2006
    ..This case illustrates that toxocariasis should be considered as a rare differential diagnostic possibility for multiple liver lesions and multifocal peripheral pulmonary opacities in young children with Wilms tumor...
  14. ncbi Multifocal bone marrow involvement in cat-scratch disease
    Sean J Hipp
    Departments of Pediatrics, University of North Carolina, Chapel Hill, NC 27599 7593, USA
    Pediatr Infect Dis J 24:472-4. 2005
    ..In both cases, magnetic resonance imaging revealed multiple enhancing bone marrow lesions consistent with clinical symptoms. Microbiologic diagnoses were established serologically...
  15. ncbi Thymic carcinoma in a child with HIV infection
    Morgan McDonald
    Division of Pediatric Hematology Oncology, The University of North Carolina, Chapel Hill, North Carolina 27599 7220, USA
    Pediatr Blood Cancer 49:1004-7. 2007
    ..This case extends the spectrum of pediatric malignancy in the setting of HIV and suggests that patients with presumed benign thymic cysts require ongoing surveillance...
  16. ncbi Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study
    Kimberly F Whelan
    Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Pediatr Blood Cancer 54:103-9. 2010
    ..Approximately 80% of children currently survive 5 years following diagnosis of their cancer. Studies based on limited data have implicated certain cancer therapies in the development of ocular sequelae in these survivors...
  17. ncbi Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study
    Daniel A Mulrooney
    Department of Pediatrics, University of Minnesota Medical School and Cancer Center, Minneapolis, MN 55455, USA
    Cancer 112:2071-9. 2008
    ..Limited data exist on the comprehensive assessment of late medical and social effects experienced by survivors of childhood and young adult acute myeloid leukemia (AML)...
  18. ncbi Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus
    Jessica Bell
    Department of Pediatrics, Division of Pediatric Hematology Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
    Pediatr Blood Cancer 50:370-1. 2008
    ..2;q15). The patient's OM was recalcitrant to conventional therapies, but showed significant improvement following treatment with rituximab...
  19. ncbi Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group
    Jonathan L Finlay
    The Children s Center for Cancer and Blood Diseases, Department of Pediatrics, Children s Hospital, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 51:806-11. 2008
    ..Children and adolescents with malignant astrocytomas recurring after initial treatment have a dismal prognosis, with only rare patients surviving 1-year beyond recurrence. The purpose of this study was to attempt to improve their survival...
  20. ncbi Maternal medication use and neuroblastoma in offspring
    Michael N Cook
    Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Am J Epidemiol 159:721-31. 2004
    ..4, 95% confidence interval: 1.4, 8.4). This preliminary finding may be due to bias, confounding, or chance, and additional studies are needed for confirmation...
  21. ncbi Residential pesticide exposure and neuroblastoma
    J L Daniels
    Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, USA
    Epidemiology 12:20-7. 2001
    ..There was no evidence of differential pesticide effects in subgroups of neuroblastoma defined by MYCN oncogene amplification or tumor stage...
  22. ncbi Positive association between congenital anomalies and risk of neuroblastoma
    Florence Menegaux
    Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
    Pediatr Blood Cancer 45:649-55. 2005
    ..27, CI = 1.22-15.0) had an elevated, but imprecise neuroblastoma risk. CONCLUSIONS: Our findings support the hypothesis of an association between neuroblastoma and congenital, especially urogenital and cardiac, anomalies...
  23. ncbi Hearing genes and cisplatin deafness: a pilot study
    Christine Knoll
    Division of Pediatric Hematology-Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7220, USA
    Laryngoscope 116:72-4. 2006
    ..35). CONCLUSIONS: It is not likely that any of the five hearing genes we examined contribute to cisplatin ototoxicity. Further study may be warranted to look at other hearing genes as possible predictors of cisplatin ototoxicity...
  24. ncbi Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline
    Wendy Landier
    Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
    J Clin Oncol 22:4979-90. 2004
    ..The Guidelines, and related Health Links, can be downloaded in their entirety at www.survivorshipguidelines.org...